Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at Morgan Stanley 23rd Annual Global
PresentationMichael UlzEquity Analyst All right. Good afternoon, everyone. Thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here, and it's my pleasure to introduce the team from Arrowhead Pharmaceuticals. To my immediate left, Christopher Anzalone, CEO; and to my far left, James Hamilton, CMO and Head of R&D. Before we get started, I just need to read a quick disclosure. For important disclosures, please see the Morgan Stanley research discl ...